The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 44,652,296 | 2,414,943 | SH | SOLE | 2,414,943 | 0 | 0 | |||
ACELYRIN INC | COM | 00445A100 | 11,577,465 | 1,715,180 | SH | SOLE | 1,715,180 | 0 | 0 | |||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 706,592 | 569,832 | SH | SOLE | 569,832 | 0 | 0 | |||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 737,271 | 225,465 | SH | SOLE | 225,465 | 0 | 0 | |||
ALIGN TECHNOLOGY INC | COM | 016255101 | 16,102,512 | 49,105 | SH | SOLE | 49,105 | 0 | 0 | |||
ALKERMES PLC | SHS | G01767105 | 13,415,675 | 495,592 | SH | SOLE | 495,592 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 27,314,379 | 182,766 | SH | SOLE | 182,766 | 0 | 0 | |||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 110,073,522 | 9,344,102 | SH | SOLE | 9,344,102 | 0 | 0 | |||
ANAPTYSBIO INC | COM | 032724106 | 18,013,883 | 799,906 | SH | SOLE | 799,906 | 0 | 0 | |||
BIOGEN INC | COM | 09062X103 | 62,523,644 | 289,958 | SH | SOLE | 289,958 | 0 | 0 | |||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 99,093,257 | 1,134,569 | SH | SOLE | 1,134,569 | 0 | 0 | |||
BLUEBIRD BIO INC | COM | 09609G100 | 5,837,019 | 4,560,171 | SH | SOLE | 4,560,171 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 7,832,479 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | |||
EHEALTH INC | COM | 28238P109 | 16,375,556 | 2,715,681 | SH | SOLE | 2,715,681 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 6,908,397 | 1,346,666 | SH | SOLE | 1,346,666 | 0 | 0 | |||
GOSSAMER BIO INC | COM | 38341P102 | 7,542,295 | 6,391,775 | SH | SOLE | 6,391,775 | 0 | 0 | |||
HUMANA INC | COM | 444859102 | 1,381,679 | 3,985 | SH | SOLE | 3,985 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 120,006,001 | 4,423,369 | SH | SOLE | 4,423,369 | 0 | 0 | |||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 31,311,859 | 2,112,811 | SH | SOLE | 2,112,811 | 0 | 0 | |||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 7,704,311 | 5,102,193 | SH | SOLE | 5,102,193 | 0 | 0 | |||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,625,264 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | |||
NEVRO CORP | COM | 64157F103 | 10,835,357 | 750,371 | SH | SOLE | 750,371 | 0 | 0 | |||
NOVOCURE LTD | ORD SHS | G6674U108 | 8,782,622 | 561,908 | SH | SOLE | 561,908 | 0 | 0 | |||
NUVATION BIO INC | COM | 67080N101 | 2,812,453 | 772,652 | SH | SOLE | 772,652 | 0 | 0 | |||
PROTHENA CORP PLC | SHS | G72800108 | 41,203,607 | 1,663,448 | SH | SOLE | 1,663,448 | 0 | 0 | |||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 3,405,660 | 732,400 | SH | SOLE | 732,400 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 25,820,180 | 5,248,004 | SH | SOLE | 5,248,004 | 0 | 0 | |||
SAGE THERAPEUTICS INC | COM | 78667J108 | 18,848,242 | 1,005,776 | SH | SOLE | 1,005,776 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 26,055,767 | 201,265 | SH | SOLE | 201,265 | 0 | 0 | |||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 52,810,705 | 1,379,590 | SH | SOLE | 1,379,590 | 0 | 0 | |||
STOKE THERAPEUTICS INC | COM | 86150R107 | 1,699,124 | 125,861 | SH | SOLE | 125,861 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 9,643,593 | 405,193 | SH | SOLE | 405,193 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 2,328,339 | 811,268 | SH | SOLE | 811,268 | 0 | 0 | |||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 853,643 | 110,719 | SH | SOLE | 110,719 | 0 | 0 | |||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 61,509,597 | 267,759 | SH | SOLE | 267,759 | 0 | 0 | |||
UROGEN PHARMA LTD | COM | M96088105 | 367,500 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | |||
VERVE THERAPEUTICS INC | COM | 92539P101 | 7,646,850 | 575,817 | SH | SOLE | 575,817 | 0 | 0 | |||
VYNE THERAPEUTICS INC | COM | 92941V308 | 1,367,482 | 445,434 | SH | SOLE | 445,434 | 0 | 0 |